At the Abilities Research Center (ARC), we are committed to using our translational research program to improving health outcomes for our diverse patient population.
We believe that when groundbreaking treatments are developed, those discoveries must be easily accessible for patients in order to have an impact. Unfortunately, many promising therapies don’t make it to patients because of delays in approval by government agencies.
To face this obstacle head-on, we aim to launch a Clinical Core to help ensure that advanced treatment options are more readily available to our patients, faster than ever before, and in a consumer-friendly manner.
While we continue to grow as a model and driver of medical innovation, we also plan to establish an Innovation Core (IC) to fund the most promising ideas not currently being explored within the medical community. With a focus on pursuing unconventional research, the Innovation Core will help position the ARC as an international leader in medical innovation.